| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Editas Medicine, Inc. | SVP, Chief Financial Officer | Common Stock | 17.5K | $30.2K | $1.72 | Jun 3, 2025 | Direct |
| Editas Medicine, Inc. | SVP, Chief Financial Officer | Stock Option (right to buy) | 34.7K | Apr 8, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. | Sep 3, 2025 | 1 | -$1.19K | 4 | Sep 4, 2025 | SVP, Chief Financial Officer |
| EDIT | Editas Medicine, Inc. | Aug 7, 2025 | 1 | -$1.75K | 4 | Aug 8, 2025 | SVP, Chief Financial Officer |
| EDIT | Editas Medicine, Inc. | Jun 3, 2025 | 1 | -$769 | 4 | Jun 4, 2025 | SVP, Chief Financial Officer |
| EDIT | Editas Medicine, Inc. | Apr 8, 2025 | 1 | $0 | 4 | Apr 8, 2025 | SVP, Chief Financial Officer |
| EDIT | Editas Medicine, Inc. | Mar 28, 2025 | 0 | $0 | 3 | Apr 8, 2025 | SVP, Chief Financial Officer |